This prospective cohort study is part of the Clinnova programme and aims to (i) identify clinical imaging and omics characteristics associated with early Multiple Sclerosis (MS) and with transitioning phases to progressive MS, as well as (ii) to investigate digital biomarkers allowing the continuous clinical monitoring of those patients.
Age ≥18
Participants are willing and able to comply with the protocol, including undergoing data and samples collection as well as study visits and examinations.
Signed informed consent form
In possession of a Healios+Me app compatible smartphone (iOS/Android)
None
University Hospital, Basel, Switzerland
Lead sponsor
Luxembourg Institute of Health
Collaborator
Research Center for Clinical Neuroimmunology and Neuroscience Basel
Collaborator